Padagis announces the relaunch of Bacitracin Ophthalmic Ointment News Padagis announces the relaunch of Bacitracin Ophthalmic Ointment
Padagis announces the launch of Brimonidine Topical Gel, 0.33% News Padagis announces the launch of Brimonidine Topical Gel, 0.33%
Padagis announces the relaunch of Evamist® (estradiol transdermal spray) News Padagis announces the relaunch of Evamist® (estradiol transdermal spray)
Padagis Announces the FDA Approval and Launch of an AB Rated Generic Version of Tobradex® Ophthalmic Suspension News Padagis Announces the FDA Approval and Launch of an AB Rated Generic Version of Tobradex® Ophthalmic Suspension
Padagis Announces the First-to-Market Launch of an AB Rated Generic Version Of Zomig® Nasal Spray News Padagis Announces the First-to-Market Launch of an AB Rated Generic Version Of Zomig® Nasal Spray
Padagis Confirms First-to-File Patent Challenge For Generic Version Of Eucrisa® News Padagis Confirms First-to-File Patent Challenge For Generic Version Of Eucrisa®
Recent Comments